AVEO
AVEO Pharmaceuticals, Inc.
AVEO
AVEO
Delisted
AVEO was delisted on the 19th of January, 2023.
55 hedge funds and large institutions have $21.4M invested in AVEO Pharmaceuticals, Inc. in 2014 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 13 increasing their positions, 18 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
49% less capital invested
Capital invested by funds: $42.3M → $21.4M (-$20.9M)
97% less call options, than puts
Call options by funds: $4K | Put options by funds: $124K
Holders
55
Holding in Top 10
2
Calls
$4K
Puts
$124K
Top Buyers
| 1 | +$921K | |
| 2 | +$239K | |
| 3 | +$188K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$167K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$166K |
Top Sellers
| 1 | -$4.25M | |
| 2 | -$1.23M | |
| 3 | -$835K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$464K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$428K |